cephalosporin c has been researched along with cefdinir in 229 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (2.18) | 18.7374 |
| 1990's | 94 (41.05) | 18.2507 |
| 2000's | 87 (37.99) | 29.6817 |
| 2010's | 37 (16.16) | 24.3611 |
| 2020's | 6 (2.62) | 2.80 |
| Authors | Studies |
|---|---|
| Blandino, G; Caccamo, F; Di Marco, R; Nicoletti, A; Nicoletti, G; Speciale, A | 1 |
| Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 2 |
| Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
| Low, DE; Scriver, SR; Simor, AE; Willey, BM | 1 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 1 |
| Inamoto, Y; Sakane, K; Takaya, T | 1 |
| Amyes, SG; Payne, DJ | 2 |
| Soejima, R | 1 |
| Iwai, N; Nakamura, H | 1 |
| Akita, H; Ikeda, M; Isohata, E; Iwata, S; Kawahara, K; Kin, Y; Kusumoto, Y; Nanri, S; Oikawa, T; Sato, Y | 1 |
| Hatakeyama, K; Hori, M; Nakano, K; Sakaguchi, N; Sugita, M; Toyonaga, Y; Yamazaki, M; Yamori, K | 1 |
| Aramaki, M; Handa, S; Kawakami, A; Motohiro, T; Oda, K; Oki, S; Sasaki, H; Tsumura, N; Yamada, S; Yoshinaga, Y | 1 |
| Erwin, ME; Gooding, BB; Jones, RN | 1 |
| Crokaert, F; Van der Linden, MP; Yourassowsky, E | 1 |
| Fujii, R; Meguro, H; Mori, A; Terashima, I | 1 |
| Nakazawa, S; Niinou, K; Sato, H | 1 |
| Akita, H; Iwata, S; Satoh, Y; Sunakawa, K | 2 |
| Fujita, M | 1 |
| Shinozaki, T | 1 |
| Iwai, N; Kasai, K; Miyazu, M; Nakamura, H; Taneda, Y; Watanabe, Y | 1 |
| Iwai, N; Miyazu, M; Nakamura, H; Watanabe, Y | 1 |
| Andoh, H; Kitoh, O; Kuno, K; Ogawa, A; Takeuchi, H; Takimoto, Y; Tomita, K | 1 |
| Aoki, S; Nishimura, T; Tabuki, K; Takagi, M | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Okura, K; Yoshida, N | 1 |
| Fujii, R; Fujita, K; Fukushima, N; Iseki, K; Murono, K; Nire, H; Sakata, H; Takahashi, Y; Wagatsuma, Y; Yoshioka, H | 1 |
| Andrews, JM; Thornber, D; Wise, R | 1 |
| Inamoto, Y; Kamimura, T; Sakane, K; Takaya, T | 2 |
| Fukushima, N; Ishikawa, A; Takahashi, S; Takase, A; Wagatsuma, Y | 1 |
| Chiba, S; Nakata, S | 1 |
| Honda, T; Takekuma, K; Tsuyuki, K | 1 |
| Aramaki, M; Handa, S; Kawakami, A; Koga, T; Motohiro, T; Oki, S; Shimada, Y; Tsumura, N; Yamada, S; Yoshinaga, Y | 1 |
| Fujita, K; Iseki, K; Kakehashi, H; Murono, K; Sakata, H; Takahashi, Y; Yoshioka, H | 1 |
| Asuka, T; Kawauchi, K; Okamoto, T; Sato, Y; Suto, Y; Takebe, Y; Tsushima, T; Yokoyama, M | 1 |
| Kibayashi, M; Watanabe, A | 1 |
| Katsushima, N; Sakamoto, M | 1 |
| Abe, T; Meguro, H; Tajima, T | 1 |
| Matsumoto, K; Nakanishi, Y; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H | 1 |
| Hirosawa, H; Ichihashi, H; Ishikawa, Y; Mikuni, K; Takahashi, S | 1 |
| Hachimori, K; Kaneda, K | 1 |
| Andoh, Y; Hayakawa, F; Kitoh, O; Kuno, K; Nakao, Y; Ogawa, A; Takeuchi, H | 1 |
| Chiba, T; Inamoto, Y; Kamimura, T; Sakane, K; Takaya, T | 1 |
| Chin, NX; Neu, HC; Saha, G | 1 |
| Kamimura, T; Kikuchi, H; Kuwahara, S; Mine, Y; Shibayama, F; Tawara, S; Wakai, Y; Yokota, Y | 1 |
| Hatano, K; Hirose, T; Kikuchi, H; Kuwahara, S; Mine, Y; Nakamoto, S; Sakamoto, H; Shibayama, F | 1 |
| Chiba, T; Inamoto, Y; Kamimura, T; Takaya, T | 1 |
| Kamimura, T; Kikuchi, H; Kuwahara, S; Matsumoto, Y; Mine, Y; Shibayama, F; Takaya, T; Tawara, S; Watanabe, Y | 1 |
| Allard, S; LeBel, M; Manseau, L; Pak, R; Richer, M; Vallée, F | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Debbia, EA; Marchese, A; Pesce, A; Saverino, D; Schito, GC | 1 |
| Ebina, K; Kato, S; Naganuma, H; Nakagawa, H; Ozawa, A | 1 |
| Hamano, S; Nakanishi, M; Tamai, I; Terasaki, T; Tsuji, A | 1 |
| Labia, R; Morand, A | 1 |
| Garcia Iglesias, MC; Perea, EJ | 1 |
| Cohen, MA; Heifetz, CL; Huband, MD; Joannides, ET; Meservey, MA; Roland, GE; Sesnie, JC; Shapiro, MA | 1 |
| Cohen, MA; Gage, JW; Heifetz, CL; Mailloux, GB; Meservey, MA; Roland, GE; Wold, SA; Yoder, SL | 1 |
| Abdelghaffar, H; Charlier, N; el Benna, J; Hakim, J; Labro, MT | 1 |
| Biedenbach, DJ; Jones, RN | 1 |
| Iwashige, H; Morishima, Y; Nakata, I; Tanaka, K; Tsujimura, K; Ueno, K; Yamazaki, K | 1 |
| García-Rodríguez, JA; García-Sánchez, JE; Trujillano-Martín, I | 1 |
| Inamoto, Y; Kawabata, K; Sakane, K; Takaya, T; Yamanaka, H | 1 |
| Bell, FW; Jordan, CL; Kasher, JS; Skaggs, TG; Ternansky, RJ | 1 |
| Bale, MJ; Jones, RN | 1 |
| Ikeda, F; Mine, Y; Yokoya, Y | 1 |
| McDonald, PJ; Pruul, H | 1 |
| Kumano, K; Kuroyama, M; Motohashi, S; Murase, S; Tomonaga, F | 1 |
| Allen, SD; Barry, AL; Fuchs, PC; Jorgensen, JH; Murray, PR; Tenover, FC | 1 |
| Andrews, JM; Cook, PJ; Honeybourne, D; Wise, R | 1 |
| Fujioka, M; Itoh, K; Matsushita, J; Namiki, Y; Okamoto, Y; Yasuda, T | 1 |
| Aleo, G; Blandino, G; Caccamo, F; Nicolosi, VM; Siracusa, V; Speciale, A | 1 |
| Breines, DM; Burnham, JC | 1 |
| Jacolot, A; Petitjean, O; Tod, M | 1 |
| Fujioka, M; Kiriyama, K; Matsushita, J; Namiki, Y; Okamoto, Y; Yasuda, T | 2 |
| Hedrick, JA; Keyserling, C; Nemeth, MA; Pichichero, ME; Rothstein, E; Tack, KJ | 1 |
| Akino, E; Hiramatsu, K; Ito, T | 1 |
| Hedrick, JA; Keyserling, CH; McCarty, J; Tack, KJ | 1 |
| Adler, M; Keyserling, C; McDonald, PJ; Tack, K; Trostmann, U | 2 |
| Kaseda, Y; Kitagawa, S; Sato, S; Sugaya, Y | 1 |
| Gwaltney, JM; Keyserling, C; Leigh, A; Rivas, P; Savolainen, S; Scheld, WM; Schenk, P; Sydnor, A; Tack, KJ | 1 |
| Bianchi, P; Drehobl, M; Griffin, TJ; Keyserling, CH; Tack, KJ | 1 |
| Brink, DN; Gooch, WM; Henry, DC; Keyserling, CH; Tack, KJ | 1 |
| Hishida, A; Kanamaru, M; Kitada, A; Nagashima, S; Obara, M; Ohishi, K | 1 |
| Fukui, M; Hamada, C; Inoue, S; Osada, S; Tomino, Y | 1 |
| Cha, JH; Chang, MH; Cho, YS; Choi, KI; Jeong, DY; Kim, D; Kim, Y; Kim, YH; Koh, HY; Kong, JY; Pae, AN; Park, SH; Park, SY | 1 |
| Inamitsu, M; Kimitsuki, T; Komiyama, S; Komune, S | 1 |
| Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T | 1 |
| Hussar, DA | 1 |
| Gooch, WM; Hedrick, J; Keyserling, CH; Nemeth, MA; Slosberg, E; Tack, KJ | 1 |
| Abe, T; Domon, H; Fukuoka, T; Ishii, C; Kakuta, M; Kawada, H; Kitayama, A; Ohya, S; Utsui, Y | 1 |
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
| Kanno, O; Kawamoto, I; Miyauchi, M; Ohya, S; Shibayama, T | 1 |
| Keyserling, CH; Langan, CE; Nemeth, MA; Rudolph, C; Siemon, G; Tack, KJ; Van Herwaarden, CL | 1 |
| Hasegawa, M; Kobayashi, I; Koyama, H; Matsuzaki, K; Nishiyama, T; Saika, T | 1 |
| Bettis, RB; Fogarty, CM; Griffin, TJ; Keyserling, CH; Nemeth, MA; Tack, KJ | 1 |
| Schenk, P; Steurer, M | 1 |
| Nelson, JS | 1 |
| Hirai, K; Hiramatsu, K; Kishi, K; Murakami, J; Nasu, M; Yamasaki, T | 1 |
| Gooch, WM; Henry, D; Keyserling, CH; McCarty, J; Nemeth, MA; Tack, KJ | 1 |
| Hotary, LH; Keyserling, CH; Leigh, AP; Nemeth, MA; Tack, KJ | 1 |
| Griffin, TJ; Keyserling, CH; McAdoo, MA; Nemeth, MA; Paster, RZ; Tack, KJ | 1 |
| Kim, MY; Lee, CS; Oh, SH; Paek, KS; Ryu, EJ; Youn, H | 1 |
| Hijioka, S; Inoue, S; Kugo, Y; Nishimura, T; Oguni, T; Sugiki, M; Sugita, K; Uemura, T; Wakamiya, E; Yoshikawa, K | 1 |
| Koga, M; Oh-i, T; Okubo, Y; Oshima, H; Yamamoto, A | 1 |
| Ishii, Y; Miyazaki, S; Okamoto, H; Tateda, K; Yamaguchi, K | 1 |
| Guay, DR | 3 |
| Block, SL; Kratzer, J; Nemeth, MA; Tack, KJ | 1 |
| Block, SL; Hedrick, JA; Kratzer, J; Nemeth, MA; Tack, KJ | 1 |
| Block, SL; Hedrick, JA; Keyserling, CH; McCarty, JM; Nemeth, MA; Tack, KJ | 1 |
| Gooch, WM; Pichichero, ME | 1 |
| Gooch, WM; Oddo, LP; Powers, JL | 1 |
| Klein, JO; McCracken, GH | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Fujiwara, T; Hiramori, K; Kawamura, M; Kimura, Y; Maesawa, C; Owada, M | 1 |
| Chihaya, Y; Furukawa, H; Itoh, F; Kato, I; Mizushima, Y; Nishimura, Y; Ohno, K; Omori, M; Sameshima, H; Ueno, M; Yabuuchi, K; Yahara, I; Yoshida, I | 1 |
| Furudoi, S; Komori, T; Ohtsuka, Y; Yoshii, T; Yoshikawa, T; Yoshioka, A | 1 |
| Akasaka, S; Inatomi, H; Matsumoto, T; Muratani, T; Takahashi, K; Yamada, Y | 1 |
| Hovde, LB; Ibrahim, KH; Ibrahim, YH; Ross, GH; Rotschafer, JC | 1 |
| Akiyama, H; Fujii, K; Iwatsuki, K; Oono, T; Yamasaki, O | 1 |
| Gwaltney, JM | 1 |
| Guttendorf, RJ; Kugler, AR; Lepsy, CS; Smith, DE | 1 |
| Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yoshimori, K | 1 |
| Abe, T; Fukuoka, T; Ito, K; Sato, Y; Sei, M | 1 |
| Fini, A; González, M; López, MA; Rodríguez, JC; Rodríguez, Z; Tolón, B; Valdés, B; Velez, H | 1 |
| Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yamanaka, N; Yoshimori, K | 1 |
| Harada, Y; Kino, M; Morikawa, Y; Nishimura, T; Sugita, K; Taniguchi, K; Uemura, T | 1 |
| Fritsche, TR; Jones, RN; Mutnick, AH; Sader, HS | 1 |
| Hashimoto, T; Kagayama, A; Niwa, T; Shiraga, T | 1 |
| Devcich, KJ; París, MM | 1 |
| Perry, CM; Scott, LJ | 1 |
| Cristobal, R; Edmiston, CE; Firszt, JB; Owen, HA; Runge-Samuelson, CL; Wackym, PA | 1 |
| Fritsche, TR; Jones, RN; Sader, HS; Streit, JM | 1 |
| Block, SL; Bukofzer, S; Busman, TA; Paris, MM | 1 |
| Che, DT; Li, WH; Lu, Q; Zhang, H | 1 |
| Kunselman, AR; Lin, HM; Lyles, RH; Williamson, JM | 1 |
| Bukofzer, S; Cifaldi, MA; Devcich, KJ; Paris, MM | 1 |
| Biedenbach, DJ; Jones, RN; Sader, HS; Streit, JM | 1 |
| Gao, L; Li, Y; Liu, J; Liu, Y; Lü, Y; Xiao, YH | 1 |
| Deng, LP; Du, YP; Jiang, XT | 1 |
| Chatterjee, A; Moland, ES; Thomson, KS | 1 |
| Busman, TA; Henry, DC; Kapral, D; Paris, MM | 1 |
| Ge, YL; Zhu, QR | 1 |
| Brook, I; Gober, AE | 3 |
| Block, SL; Cifaldi, M; Gu, Y; Paris, MM | 1 |
| Brook, I | 1 |
| Brook, I; Foote, PA | 1 |
| Cartier, LL; Cheung, BW; Ji, P; Sawchuk, RJ | 1 |
| Bonsu, BK; Cohen, DM; Dorst, P; Sawicki, L; Shuler, L | 1 |
| Chiu, YL; Holas, C; Kapral, D; Notario, G | 1 |
| Bowlware, KL; Ghaffar, F; Lozano-Hernandez, J; McCracken, GH | 1 |
| Arguedas, A; Dagan, R; Hoberman, A; Leibovitz, E; Paris, M; Pichichero, M | 1 |
| Cao, GY; Chen, ZJ; Shi, YG; Wu, XJ; Yu, JC; Zhang, J | 1 |
| Hadley, JA | 1 |
| Decorby, MR; Hoban, DJ; Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
| Jones, RN; Sader, HS | 2 |
| Del Rosso, J | 1 |
| Alpegiani, M; Cabri, W; Ghetti, P; Justo-Erbez, A; Monedero-Perales, MC; Muñoz-Ruiz, A; Pérez-Martínez, JI; Pozzi, G; Villalón-Rubio, R | 1 |
| Akinlade, BK; Block, SL; Busman, TA; Halpern, MT; Mackinnon, GE; Nilius, AM; Notario, GF; Schmier, JK | 1 |
| Bharathi, CH; Dandala, R; Naidu, A; Rani, A; Rao, KV; Reddy, AV | 1 |
| Seaman, JW; Stamey, JD; Young, DM | 1 |
| Akinlade, BK; Busman, TA; Cifaldi, M; Elston, D; Giordano, PA; Nilius, AM; Notario, GF; Weber, K | 1 |
| Fujita, T; Kumagai, Y; Kuroyama, S; Maeda, M; Majima, M; Nakamura, K; Nakamura, T; Nomura, K; Ohtani, Y; Ozaki, M; Sahashi, K; Shichijo, K; Yamazaki, A; Yokota, S | 1 |
| Dwivedi, A; Jain, R; Mishra, R | 1 |
| Aguilar, L; Alou, L; Cafini, F; Giménez, MJ; González, N; Granizo, JJ; Martín-Herrero, JE; Prieto, J; Sevillano, D; Torrico, M | 1 |
| Ida, T; Kato, Y; Maebashi, K; Sanbongi, Y; Takahata, S | 1 |
| Aleem, O; Kuchekar, B; Late, S; Pore, Y | 1 |
| Etani, Y; Mushiake, S; Nakayama, M; Ozono, K; Tajiri, H | 1 |
| Lancaster, J; Schainker, E; Sylvia, LM | 1 |
| Alhaique, F; Kort, J; Sweileh, W; Zaid, AN | 1 |
| Ahmad, J; Chen, J | 1 |
| Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL | 1 |
| Cabana, MD; Donahue, C; Jaffe, A; Lowers, J; Uba, A; Zenel, JA | 1 |
| Eisenhart, A; Mookadam, M | 1 |
| Higashide, M; Hiramatsu, K; Kikuchi, K; Ohtsuka, M; Okada, K; Shundo, K; Sunakawa, K | 1 |
| Hanauer, SB | 1 |
| Fukumoto, K; Matsui, K; Oishi, T; Taguchi, T; Tsukano, S; Uchiyama, M; Ueno, K | 1 |
| Cha, KH; Cho, W; Hwang, SJ; Kang, YS; Park, HJ; Park, J | 1 |
| Hur, JK; Kang, JH; Kim, JH; Lee, KY; Lee, SY | 1 |
| Beckius, ML; Glasser, JS; Markelz, AE; Mende, K; Murray, CK; Zera, WC | 1 |
| Gouda, AA; Hashem, H; Hassan, W | 1 |
| Ahmad, L; Iqbal, Z; Javed, K; Khan, A; Khan, MI; Nasir, F; Shah, Y | 1 |
| Chen, J; Jiang, B; Lou, H; Ruan, Z; Yu, L | 1 |
| Chen, Z; Fan, G; Hang, T; Li, J; Li, Y; Wang, L; Xie, R | 1 |
| Chen, ZZ; Feng, F; Hu, CQ; Wang, N; Zhang, DS | 1 |
| Almudevar, A; Block, SL; Casey, JR; Hedrick, J; Pichichero, ME | 1 |
| Goldbach, HS; LaGrone, LN; Maleta, KM; Manary, MJ; Meuli, GJ; Trehan, I; Wang, RJ | 1 |
| Pichichero, ME | 1 |
| Jin, HE; Kim, CK; Kim, IB; Maeng, HJ | 1 |
| Guo, B; Jin, M; Li, N; Li, X; Yi, J; Zhong, S | 1 |
| Jena, PK; Mehta, T; Nareshkumar, G; Prajapati, B; Seshadri, S; Singh, S | 1 |
| Al-Badr, AA; Alasseiri, FA | 1 |
| MacKenzie, A | 1 |
| Das, N; Salam, JA; Selvi, A | 1 |
| Cho, KH; Chow, ECY; Chung, SJ; Jin, HE; Kim, IB; Kim, M; Kim, YC; Maeng, HJ; Noh, CK; Pang, KS; Quach, HP; Yoon, IS | 1 |
| Lewin, AB; Murphy, TK; Mutch, PJ; Parker-Athill, EC; Storch, EA | 1 |
| Eguchi, H; Hotta, F; Kusujima, K; Kuwahara, T; Mitamura, Y; Naito, T | 1 |
| Cotes, C; Riascos, R; Swischuk, LE | 1 |
| Manno, M; Wing, R | 1 |
| Das, D; Das, N; Selvi, A | 1 |
| Cao, J; Chui, D; Huang, H; Wang, H; Xiao, S | 1 |
| Cheng, F; Liu, L | 1 |
| Abou-Taleb, NH; El-Ashry, SM; El-Sherbiny, DT; El-Wasseef, DR | 1 |
| Patel, K; Patel, MH; Sawant, KK | 1 |
| Bi, X; Chen, Z; Fan, G; Li, J; Sun, D; Tang, Y | 1 |
| Feng, YC; Hu, CQ; Li, J; Liu, Y; Wang, C | 1 |
| Kaul, M; LaVoie, EJ; Mark, L; Parhi, AK; Pilch, DS | 1 |
| Chai, X; Gao, X; Jiang, Z; Pan, G; Wang, Y; Yang, F; Zhao, X; Zhu, Y | 1 |
| Amii, R; DeUgarte, DA; Jude, CM; Krishnadasan, A; Moran, GJ; Morim, A; Mower, WR; Pathmarajah, K; Saltzman, DJ; Talan, DA; Wu, JX | 1 |
| Cho, HJ; Cho, KH; Choi, HG; Jee, JP; Kang, JY; Maeng, HJ; Shin, DY | 1 |
| Chayakulkeeree, M; Songkhla, MN | 1 |
| Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Peng, J; Sun, H; Sun, P; Wang, C; Wang, H | 1 |
| Fujisawa, M; Kitagawa, K; Nomi, M; Shigemura, K; Takami, N; Yamada, N | 1 |
| Årdal, C; Hudson, J; Kållberg, C; Klein, E; Laxminarayan, R; Lindbæk, M; Outterson, K; Røttingen, JA; Salvesen Blix, H | 1 |
| Noel, JM; Panchoo, AV | 1 |
| Shi, CY; Wang, JF; Ying, HZ | 1 |
| Al Attraqchi, Y; Al Okla, S; Asaad, A; Kurbet, S; Prashanth, GP | 1 |
| Bodur, İ; Göktuğ, A; Karacan, CD; Öztürk, B; Tekeli, A; Tuygun, N | 1 |
19 review(s) available for cephalosporin c and cefdinir
| Article | Year |
|---|---|
[A new oral cephem, cefdinir: its structure-activity relationships and biological profile].
Topics: Animals; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Humans; Intestinal Absorption; Structure-Activity Relationship | 1992 |
[Cefdinir].
Topics: Animals; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefdinir; Cephalosporins; Drug Evaluation; Drug Resistance, Microbial; Drug Stability; Hexosyltransferases; Humans; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding | 1992 |
[Research and development of new oral cephems, cefixime and cefdinir].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship | 1993 |
Two cases of confluent and reticulate papillomatosis: successful treatments of one case with cefdinir and another with minocycline.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Arm; Cefdinir; Cephalosporins; Female; Humans; Male; Minocycline; Neck; Papilloma; Skin Neoplasms; Thorax | 2000 |
Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin.
Topics: Adult; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Humans; Microbial Sensitivity Tests | 2000 |
Summary: role of a new oral cephalosporin, cefdinir, for therapy of infections of infants and children.
Topics: Acute Disease; Administration, Oral; Cefdinir; Cephalosporins; Child; Child, Preschool; Humans; Infant; Otitis Media; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 2000 |
Cefdinir: an expanded-spectrum oral cephalosporin.
Topics: Administration, Oral; Anti-Infective Agents; Cefdinir; Cephalosporins; Clinical Trials as Topic; Databases, Factual; Humans; Microbial Sensitivity Tests; Respiratory Tract Diseases; Skin Diseases; Treatment Outcome | 2000 |
Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin.
Topics: Administration, Oral; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Humans | 2002 |
Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections.
Topics: Adult; Anti-Infective Agents; Cefdinir; Cephalosporins; Child; Humans; Skin Diseases, Bacterial; Soft Tissue Infections | 2004 |
Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
[Effects of cefdinir in pediatric infectious diseases].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefdinir; Cephalosporins; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic | 2005 |
A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Female; Humans; Male; Patient Satisfaction; Randomized Controlled Trials as Topic; Single-Blind Method; Smell; Suspensions; Taste | 2005 |
The efficacy of cefdinir in acute bacterial rhinosinusitis.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Cefdinir; Cephalosporins; Drug Administration Schedule; Haemophilus Infections; Haemophilus influenzae; Humans; Moraxella catarrhalis; Moraxellaceae Infections; Pneumococcal Infections; Randomized Controlled Trials as Topic; Sinusitis; Streptococcus pneumoniae | 2006 |
Therapeutic experience with cefdinir in the treatment of uSSSIs.
Topics: Adult; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Female; Humans; Male; Skin Diseases, Bacterial | 2006 |
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
Topics: Administration, Oral; Animals; Cefdinir; Cephalosporins; Humans; Respiratory Tract Infections; Skin Diseases, Infectious | 2007 |
Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Bacterial Agents; beta-Cyclodextrins; Cefdinir; Cephalosporins; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2008 |
Otitis media.
Topics: Age Factors; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Child, Preschool; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Moraxella catarrhalis; Otitis Media; Otitis Media with Effusion; Otoscopy; Streptococcus pneumoniae; Time Factors; Tympanic Membrane | 2013 |
Cefdinir.
Topics: Animals; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Chemistry, Pharmaceutical; Drug Interactions; Drug Resistance, Bacterial; Drug Stability; Humans; Molecular Structure | 2014 |
Emergent "Bloody Diarrhea" Associated with the Use of Oral Cefdinir in Young Children: A Brief Report and Review of Literature.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Infant; Iron | 2023 |
47 trial(s) available for cephalosporin c and cefdinir
| Article | Year |
|---|---|
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
[Pharmacokinetics and clinical effects of cefdinir 10% fine granules in pediatrics].
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Cloxacillin; Eating; Escherichia coli; Female; Humans; Infant; Male; Methicillin; Microbial Sensitivity Tests; Streptococcus pyogenes | 1992 |
[Pharmacokinetic and clinical studies of cefdinir in the pediatric field. Pediatric Study Group of Cefdinir].
Topics: Administration, Oral; Adolescent; Age Factors; Bacteria; Bacterial Infections; Biological Availability; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Resistance, Microbial; Humans; Infant | 1991 |
[A clinical study on cefdinir in pediatrics].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1990 |
[Clinical studies on cefdinir granules in pediatric field].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male | 1990 |
Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses.
Topics: Adult; Blister; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Diffusion; Extracellular Space; Humans; Male | 1995 |
Impairment of cefdinir absorption by iron ion.
Topics: Adult; Cations; Cefdinir; Cephalosporins; Humans; Intestinal Absorption; Iron; Male; Reference Values | 1993 |
Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.
Topics: Administration, Oral; Adult; Aged; Bronchi; Bronchoalveolar Lavage Fluid; Cefdinir; Cephalosporins; Epithelium; Female; Humans; Lung; Macrophages, Alveolar; Male; Microbial Sensitivity Tests; Middle Aged | 1996 |
A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group.
Topics: Adolescent; Ambulatory Care; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Office Visits; Pharyngitis; Primary Health Care; Single-Blind Method; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome; Treatment Refusal | 1997 |
Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study Group.
Topics: Cefdinir; Cephalexin; Cephalosporins; Child; Child, Preschool; Double-Blind Method; Humans; Infant; Skin; Skin Diseases, Infectious | 1997 |
Cefdinir versus amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Diarrhea; Female; Humans; Infant; Male; Otitis Media, Suppurative; Penicillins | 1997 |
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefdinir; Cephalosporins; Child; Clavulanic Acids; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Single-Blind Method; Sinusitis; Treatment Outcome | 1997 |
Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cefdinir; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome; United States | 1997 |
Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cefdinir; Cephalosporins; Double-Blind Method; Female; Humans; Male; Middle Aged; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1998 |
Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bacteria; Blood Proteins; Cefdinir; Cephalosporins; Dialysis Solutions; Female; Half-Life; Humans; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Protein Binding | 1998 |
Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Penicillins; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1999 |
International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchitis; Cefdinir; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome | 2000 |
Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bronchitis; Cefdinir; Cefprozil; Cephalosporins; Child; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Pharyngitis; Prospective Studies; Tonsillitis | 2000 |
Efficacy and safety of cefdinir in the treatment of maxillary sinusitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bacterial Infections; Cefdinir; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Treatment Outcome | 2000 |
Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Double-Blind Method; Female; Humans; Male; Middle Aged; Penicillin V; Penicillins; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 1999 |
Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefaclor; Cefdinir; Cephalosporins; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2000 |
A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Cefdinir; Cephalosporins; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Sputum; Treatment Outcome | 2000 |
Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media.
Topics: Acute Disease; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media; Treatment Outcome | 2000 |
Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy.
Topics: Acoustic Impedance Tests; Acute Disease; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Female; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Otitis Media; Otitis Media with Effusion; Penicillin Resistance; Streptococcus pneumoniae; Streptococcus pyogenes; Treatment Outcome | 2000 |
Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media, Suppurative; Treatment Outcome | 2000 |
Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media, Suppurative; Treatment Outcome | 2000 |
Comparison of cefdinir and penicillin V in the treatment of pediatric streptococcal tonsillopharyngitis.
Topics: Cefdinir; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Penicillin V; Penicillins; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2000 |
Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Azithromycin; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Female; Humans; Male; Single-Blind Method; Smell; Suspensions; Taste | 2000 |
[Clinical efficacy and bacteriological studies of clarithromycin and cefdinir against group A beta-hemolytic streptococcal tonsillopharyngitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Evaluation; Humans; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2003 |
Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Probability; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Treatment Outcome | 2004 |
Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate oral suspensions.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Clinical Trials, Phase IV as Topic; Drug Tolerance; Female; Humans; Infant; Male; Otitis Media; Parents; Patient Compliance; Patient Satisfaction; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Suspensions; Treatment Outcome | 2004 |
[Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cephalosporins; Community-Acquired Infections; Humans; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Single-Blind Method; Staphylococcal Infections; Streptococcal Infections | 2004 |
Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Cefdinir; Cephalosporins; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Severity of Illness Index; Sinusitis; Treatment Outcome | 2004 |
Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxycillin-clavulanate.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Colony Count, Microbial; Haemophilus influenzae; Humans; Moraxella catarrhalis; Nasopharynx; Otitis Media; Streptococcus pneumoniae; Time Factors | 2005 |
A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
Topics: Acoustic Impedance Tests; Acute Disease; Administration, Oral; Analgesics; Analgesics, Non-Narcotic; Anti-Infective Agents; Anti-Inflammatory Agents; Azithromycin; Cefdinir; Cephalosporins; Child, Preschool; Diarrhea; Drug Administration Schedule; Female; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Male; Meningococcal Vaccines; Otitis Media; Pneumococcal Vaccines; Prospective Studies; Single-Blind Method; Streptococcus pneumoniae; Time Factors; Treatment Outcome; Tympanic Membrane | 2005 |
Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily.
Topics: Acute Disease; Anti-Infective Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Humans; Infant; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Soft Tissue Infections; Streptococcus pneumoniae; Treatment Outcome | 2006 |
A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Cefdinir; Cephalosporins; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media with Effusion; Paracentesis; Penicillin Resistance; Pneumococcal Infections; Recurrence; Risk Factors; Streptococcus pneumoniae; Treatment Outcome | 2006 |
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Otitis Media; Parents; Prospective Studies; Treatment Outcome | 2006 |
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Cefdinir; Cellulitis; Cephalexin; Cephalosporins; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Skin Diseases, Bacterial; Staphylococcus aureus; Staphylococcus epidermidis; Wound Infection | 2006 |
Effect of L-phenylalanine supplementation and a high-protein diet on pharmacokinetics of cefdinir in healthy volunteers: an exploratory study.
Topics: Adult; Alanine Transaminase; Anti-Bacterial Agents; Area Under Curve; Blood Urea Nitrogen; Cefdinir; Cephalosporins; Cross-Over Studies; Dietary Proteins; Dietary Supplements; Humans; Intestinal Absorption; Kidney Function Tests; Male; Metabolic Clearance Rate; Nutrition Policy; Phenylalanine; Pilot Projects; Time Factors; Triglycerides | 2007 |
Comparative bioavailability of two cefdinir suspension formulations in Middle Eastern healthy volunteers after single oral administration.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Calibration; Cefdinir; Cephalosporins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cross-Over Studies; Drugs, Generic; Humans; Male; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Suspensions; Therapeutic Equivalency | 2008 |
Prophylactic cefdinir for pediatric cases of complicated urinary tract infection.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefdinir; Cephalosporins; Cohort Studies; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Humans; Infant; Male; Secondary Prevention; Treatment Outcome; Urinary Tract Infections | 2011 |
Bioequivalence evaluation of cefdinir in healthy fasting subjects.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Cross-Over Studies; Fasting; Humans; Male; Quality Control; Therapeutic Equivalency | 2012 |
Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Drug Administration Schedule; Follow-Up Studies; Humans; Infant; Otitis Media; Prospective Studies; Single-Blind Method; Treatment Outcome | 2012 |
Antibiotics as part of the management of severe acute malnutrition.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child, Preschool; Combined Modality Therapy; Double-Blind Method; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Protein-Energy Malnutrition; Risk; Treatment Outcome; Weight Gain | 2013 |
Cefdinir for recent-onset pediatric neuropsychiatric disorders: a pilot randomized trial.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Obsessive-Compulsive Disorder; Pilot Projects; Tic Disorders | 2015 |
Antibiotics-First Versus Surgery for Appendicitis: A US Pilot Randomized Controlled Trial Allowing Outpatient Antibiotic Management.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactams; Cefdinir; Cephalosporins; Child; Cost-Benefit Analysis; Drug Therapy, Combination; Ertapenem; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Outpatients; Pain; Pilot Projects; Quality of Life; Severity of Illness Index; Treatment Outcome; United States; Young Adult | 2017 |
163 other study(ies) available for cephalosporin c and cefdinir
| Article | Year |
|---|---|
Bactericidal activity and postantibiotic effect of cefdinir (Cl 983, FK 482) against selected pathogens.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefdinir; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Kinetics; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin | 1992 |
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Fleroxacin; Fluoroquinolones; Haemophilus influenzae; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin | 1992 |
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.
Topics: Anti-Infective Agents; Cefdinir; Ceftizoxime; Cephalosporins; Diffusion; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Control; Quinolones | 1992 |
Comparative in vitro activity of cefdinir (CI-983; FK-482) against staphylococci, gram-negative bacilli and respiratory tract pathogens.
Topics: Bacteria; Cefdinir; Cephalosporins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Respiratory System; Staphylococcus | 1992 |
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Drug Evaluation, Preclinical; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 1992 |
The sensitivity of clinical bacteria isolated in Scotland to the oral cephalosporin, cefdinir.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Microbial Sensitivity Tests; Scotland | 1992 |
[Pharmacokinetic studies on oral antibiotics in pediatrics. V. A pharmacokinetic study on cefdinir in pediatrics].
Topics: Administration, Oral; Adolescent; Age Factors; Cefdinir; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Eating; Humans; Infant | 1992 |
[The influence of cefdinir on the intestinal bacterial flora].
Topics: Animals; beta-Lactamases; Cefdinir; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae; Feces; Female; Humans; Infant; Intestines; Male; Mice; Mice, Inbred ICR | 1992 |
Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.
Topics: Cefdinir; Cephalosporins; Diagnostic Errors; Enterobacter; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests | 1992 |
Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae.
Topics: Cefaclor; Cefdinir; Cephalosporins; Colony Count, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Streptococcus pneumoniae | 1992 |
[Clinical evaluation of cefdinir 10% granules in children].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1991 |
[Clinical studies on 10% cefdinir granules in pediatric infections].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1991 |
[A clinical study on cefdinir 10% granule in pediatrics].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1991 |
[A clinical study on cefdinir in pediatric field].
Topics: Acute Disease; Administration, Oral; Age Factors; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Female; Humans; Male | 1991 |
[Clinical studies of cefdinir in pediatric infections].
Topics: Acute Disease; Administration, Oral; Adolescent; Age Factors; Bacteria; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Respiratory Tract Infections; Urinary Tract Infections | 1991 |
[Clinical evaluation of cefdinir 5% fine granules in pediatrics].
Topics: Acute Disease; Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1991 |
[Pharmacokinetic, bacteriological and clinical evaluations of cefdinir 10% fine granules in pediatrics].
Topics: Administration, Oral; Adolescent; Age Factors; Bacteria; Bacterial Infections; Biological Availability; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Female; Half-Life; Humans; Infant; Male | 1991 |
[Laboratory and clinical studies on cefdinir (10% fine granules) in pediatric field].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1991 |
[Laboratory and clinical studies of cefdinir 5% and 10% fine granules in pediatric field].
Topics: Administration, Oral; Adolescent; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Humans; Infant | 1991 |
[Pharmacokinetic, bacteriological and clinical studies on cefdinir fine granules in the field of pediatrics].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Female; Humans; Infant; Male | 1991 |
The in-vitro activity of cefdinir (FK482), a new oral cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefdinir; Cephalosporins; Enzyme Stability; Microbial Sensitivity Tests | 1991 |
[Studies on FK482 (Cefdinir). IV. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]- 3-substituted cephalosporin derivatives].
Topics: Animals; Bacteria; Cefdinir; Cephalosporins; Escherichia coli; Rats; Staphylococcus aureus; Structure-Activity Relationship | 1990 |
[Pharmacokinetic and clinical studies of cefdinir in pediatric field].
Topics: Administration, Oral; Adolescent; Age Factors; Bacterial Infections; Bronchitis; Cefdinir; Cephalosporins; Child; Drug Evaluation; Humans; Male; Pharyngitis | 1990 |
[Pharmacokinetic and clinical studies on cefdinir fine granules in children].
Topics: Administration, Oral; Adolescent; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1990 |
[Clinical investigation of cefdinir in the pediatric field].
Topics: Administration, Oral; Age Factors; Bacteria; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Respiratory Tract Infections | 1990 |
[Pharmacokinetics and clinical effects of cefdinir 5% fine granules in pediatrics].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Pharyngitis; Pneumonia; Urinary Tract Infections | 1990 |
[Studies on FK482 (Cefdinir). III. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-aryl-2-hydroxyiminoacetamido]-3-vinyl-3- cephem-4-carboxylic acid derivatives].
Topics: Animals; Bacteria; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Intestinal Absorption; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1990 |
[Clinical and pharmacokinetic evaluation of cefdinir in children].
Topics: Administration, Oral; Age Factors; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Respiratory Tract Infections; Skin Diseases, Infectious; Urinary Tract Infections | 1990 |
[Clinical studies on cefdinir in pediatric infections].
Topics: Administration, Oral; Age Factors; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male | 1990 |
[Laboratory and clinical studies on cefdinir in pediatric field].
Topics: Administration, Oral; Adolescent; Age Factors; Bacterial Infections; Cefdinir; Cephalosporins; Child; Drug Evaluation; Female; Humans; Male | 1990 |
[A clinical evaluation of cefdinir in pediatric infections].
Topics: Administration, Oral; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Staphylococcus aureus; Streptococcus pyogenes | 1990 |
[Clinical evaluation of a new oral cephem, cefdinir, in children].
Topics: Administration, Oral; Adolescent; Age Factors; Bacterial Infections; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Staphylococcus aureus | 1990 |
[Clinical evaluation of cefdinir in pediatric field].
Topics: Administration, Oral; Bacteria; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Impetigo; Male; Respiratory Tract Infections | 1990 |
[Clinical study on cefdinir in pediatric field].
Topics: Acute Disease; Administration, Oral; Adolescent; Age Factors; Bacteria; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Respiratory Tract Infections | 1990 |
[Laboratory and clinical studies on cefdinir in pediatric field].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Child; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Male | 1990 |
[Studies on FK482. II. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-substituted acetamido]-3-vinyl-3-cephem-4-carboxylic acid derivatives].
Topics: Animals; Bacteria; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Intestinal Absorption; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1990 |
Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
Topics: Amoxicillin; beta-Lactamases; Cefdinir; Cephalosporins; Clavulanic Acids; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1989 |
In vivo antibacterial activity of FK482, a new orally active cephalosporin.
Topics: Administration, Oral; Animals; Bacterial Infections; Cefaclor; Cefdinir; Cephalosporins; Male; Mice; Mice, Inbred ICR; Pneumonia; Pyelonephritis; Rabbits | 1988 |
Pharmacokinetics of FK482, a new orally active cephalosporin, in animals.
Topics: Administration, Oral; Animals; Bile; Cefdinir; Cephalosporins; Dogs; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Rabbits; Rats; Tissue Distribution | 1988 |
FK 482, a new orally active cephalosporin synthesis and biological properties.
Topics: Administration, Oral; Animals; Cefdinir; Cephalosporins; Dogs; Mice; Rabbits; Rats | 1988 |
In vitro antibacterial activity of FK482, a new orally active cephalosporin.
Topics: Administration, Oral; Ampicillin; beta-Lactamases; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests; R Factors | 1988 |
[Reevaluation of current antimicrobials. cefdinir (discussion)].
Topics: Bacteria; Bacterial Infections; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Humans | 1995 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Culture Media; Drug Interactions; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus | 1995 |
Antibiotic-associated hemorrhagic colitis without Clostridium difficile toxin in children.
Topics: Adolescent; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Colitis; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Sulbactam | 1995 |
Intestinal brush-border transport of the oral cephalosporin antibiotic, cefdinir, mediated by dipeptide and monocarboxylic acid transport systems in rabbits.
Topics: Acetates; Animals; Biological Transport, Active; Carboxylic Acids; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Dipeptides; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Male; Membrane Potentials; Microvilli; Rabbits | 1993 |
Interaction of cefdinir with beta-lactamases.
Topics: Bacteria; Cefdinir; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Escherichia coli; Kinetics; Penicillinase | 1994 |
Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamases; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Resistance, Multiple; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests | 1994 |
In vitro evaluation of cefdinir (FK482), a new oral cephalosporin with enhanced antistaphylococcal activity and beta-lactamase stability.
Topics: Bacteria; beta-Lactamases; Cefdinir; Cephalosporins; Enterobacteriaceae; Enzyme Stability; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Staphylococcus; Streptococcus | 1994 |
In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models.
Topics: Administration, Oral; Animals; beta-Lactamases; Cefdinir; Cephalosporins; Female; Haemophilus Infections; Haemophilus influenzae; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 1994 |
Cefdinir (CI-983), a new oral amino-2-thiazolyl cephalosporin, inhibits human neutrophil myeloperoxidase in the extracellular medium but not the phagolysosome.
Topics: Blood Bactericidal Activity; Calcimycin; Cefdinir; Cell Degranulation; Cephalosporins; Cytochalasin B; Extracellular Space; Humans; Hydrogen Peroxide; In Vitro Techniques; Luminescent Measurements; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peroxidase; Phagosomes; Tetradecanoylphorbol Acetate; Zymosan | 1994 |
Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
Topics: Administration, Oral; Cefdinir; Cefprozil; Ceftizoxime; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Evaluation Studies as Topic; False Positive Reactions; Humans; Microbial Sensitivity Tests; Proteus vulgaris; Providencia | 1994 |
Cefdinir: in vitro activity study and effect of human serum.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Blood Physiological Phenomena; Cefdinir; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1993 |
The synthesis and biological characteristics of new orally active cephems.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Intestinal Absorption; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley | 1993 |
Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
Topics: Anti-Infective Agents; Cefdinir; Cefepime; Cefmetazole; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones | 1993 |
[Antibacterial activity of cefdinir and omeprazole against Helicobacter pylori and their inhibition on H. pylori-producing urease].
Topics: Cefdinir; Cephalosporins; Drug Synergism; Helicobacter pylori; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Omeprazole; Urease | 1993 |
Stability of cefdinir (C1-983, FK482) to extended-spectrum plasmid-mediated beta-lactamases.
Topics: beta-Lactamases; Cefdinir; Cephalosporins; Escherichia coli; Plasmids | 1993 |
Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils.
Topics: Bacteria; Blood Bactericidal Activity; Cefdinir; Cephalosporins; Escherichia coli; Humans; Neutrophils; Phagocytosis; Staphylococcus aureus | 1993 |
[Protein binding of oral cephems in patients with chronic renal failure].
Topics: Carrier Proteins; Cefdinir; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Humans; Kidney Failure, Chronic; Palmitic Acid; Palmitic Acids; Renal Dialysis | 1993 |
Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methods.
Topics: Cefdinir; Cephalosporins; Microbial Sensitivity Tests; Quality Control; Streptococcus pneumoniae | 1995 |
Method development for the determination of cefdinir and its related substances by high-performance liquid chromatography.
Topics: Calibration; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; Indicators and Reagents; Quality Control; Reproducibility of Results; Solutions | 1996 |
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Penicillins; Sicily; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 1996 |
The effects of quinolones on the adherence of type-1 fimbriated Escherichia coli to mannosylated agarose beads.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Buffers; Cefdinir; Cephalosporins; Drug Interactions; Escherichia coli; Fluoroquinolones; Mannose; Methylmannosides; Naphthyridines; Sensitivity and Specificity; Sepharose; Tetracycline | 1995 |
Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cefdinir; Cephalosporins; Drug Interactions; Half-Life; Isoquinolines; Male; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines | 1996 |
Degradation kinetics and isomerization of cefdinir, a new oral cephalosporin, in aqueous solution. 1.
Topics: Administration, Oral; Cefdinir; Cephalosporins; Hydrogen-Ion Concentration; Hydrolysis; Molecular Conformation; Solutions | 1996 |
Degradation kinetics and isomerization of cefdinir, a new oral cephalosporin, in aqueous solution. 2. Hydrolytic degradation pathway and mechanism for beta-lactam ring opened lactones.
Topics: Administration, Oral; Cefdinir; Cephalosporins; Hydrolysis; Solutions; Stereoisomerism | 1996 |
[Evaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis--effect of various antibiotics on extracellular release of verotoxin].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Toxins; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Enteritis; Escherichia coli Infections; Escherichia coli O157; Hemolytic-Uremic Syndrome; Humans; Kanamycin Resistance; Purpura, Thrombotic Thrombocytopenic; Shiga Toxin 1 | 1997 |
Characteristics of cefdinir uptake by rabbit small intestinal brush-border membrane vesicles.
Topics: Animals; Carboxylic Acids; Cefdinir; Cephalosporins; Drug Interactions; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Kinetics; Microvilli; Rabbits; Temperature | 1997 |
Pharmacokinetic study of an oral cephalosporin, cefdinir, in hemodialysis patients.
Topics: Administration, Oral; Adult; Cefdinir; Cephalosporins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1998 |
Cefdinir--a new oral cephalosporin.
Topics: Administration, Oral; Adult; Antacids; Anti-Infective Agents; Candidiasis, Vulvovaginal; Cefdinir; Cephalosporins; Child; Child, Preschool; Controlled Clinical Trials as Topic; Diarrhea; Dose-Response Relationship, Drug; Drug Interactions; Fees, Pharmaceutical; Female; Humans; Iron | 1998 |
Parke-Davis announces market availability of Omnicef--a new, broad-spectrum cephalosporin antibiotic.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefdinir; Cephalosporins; Humans | 1999 |
Studies on novel 3-isoxazolylvinyl-cephalosporins: II. Synthesis and biological activity of 7-[2-(2-aminothiazol-4-yl)-2-hydroxy-iminoacetamido] derivatives.
Topics: Animals; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 1998 |
Congenital malformation of the inner ear associated with recurrent meningitis.
Topics: Anti-Infective Agents; Cefdinir; Cephalosporins; Cerebrospinal Fluid Otorrhea; Child, Preschool; Cochlea; Ear Diseases; Ear, Inner; Female; Fistula; Haemophilus Infections; Hearing Disorders; Humans; Meningitis, Bacterial; Recurrence; Tomography, X-Ray Computed; Tympanic Membrane | 1999 |
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins | 1999 |
New drugs 99, Part IV.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cefdinir; Cephalosporins; Citalopram; Drug Therapy; Etanercept; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Serotonin Receptor Agonists; Telmisartan; Tetrazoles; Triazoles; Tryptamines; United States; United States Food and Drug Administration | 1999 |
[In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Lactams; Male; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Prodrugs; Streptococcus pneumoniae | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Carbapenems; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Half-Life; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Stereoisomerism; Structure-Activity Relationship | 1999 |
[In vitro activity of faropenem against beta-lactamase producing clinical isolates].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Humans; Lactams; Microbial Sensitivity Tests | 2000 |
Red stools and omnicef.
Topics: Anti-Infective Agents; Cefdinir; Cephalosporins; Child; Color; Feces; Humans; Infant; Male | 2000 |
Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cefdinir; Cephalosporins; Chlorocebus aethiops; Clindamycin; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Humans; Latex Fixation Tests; Levofloxacin; Microbial Sensitivity Tests; Miocamycin; Ofloxacin; Roxithromycin; Shiga Toxin 1; Shiga Toxin 2; Time Factors; Vero Cells | 2000 |
Synthesis and antibacterial activities of novel C(3)-aminopyrimidinyl substituted cephalosporins including against respiratory tract pathogens.
Topics: Anti-Infective Agents; Cefdinir; Cephalosporins; Microbial Sensitivity Tests; Pyrimidines; Respiratory System; Structure-Activity Relationship | 2000 |
[Antimicrobial susceptibility and serotypes of Streptococcus pneumoniae isolated from the patients with respiratory tract infections in Hokusetsu Area of Osaka].
Topics: Anti-Bacterial Agents; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clindamycin; Erythromycin; Humans; Minocycline; Penicillin G; Penicillins; Respiratory Tract Infections; Serotyping; Streptococcus pneumoniae | 2000 |
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Humans; Japan; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure.
Topics: Acute Disease; Acute Kidney Injury; Anti-Infective Agents; Anti-Inflammatory Agents; Biopsy; Bronchitis; C-Reactive Protein; Cefdinir; Cephalosporins; Creatinine; Disease Progression; Drug Therapy, Combination; Famotidine; Female; Histamine H2 Antagonists; Humans; Kidney; Kidney Function Tests; Methylprednisolone; Middle Aged; Nephritis, Interstitial; Ofloxacin; Prednisolone; Radionuclide Imaging | 2001 |
[Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (5)--Six-month repeated oral dose toxicity study and supplement study in rats].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Blood Cells; Blood Chemical Analysis; Body Weight; Bone Marrow Cells; Cefdinir; Cephalosporins; Clostridioides difficile; Drinking; Drug Administration Schedule; Eating; Enterobacteriaceae; Female; Hearing; Intestines; Liver; Male; Occult Blood; Organ Size; Rats; Streptococcus; Urinalysis | 2001 |
Evaluation of oral antimicrobial agent levels in tooth extraction sites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alveolar Process; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefmenoxime; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillins; Prodrugs; Staphylococcal Infections; Streptococcus; Talampicillin; Time Factors; Tooth Diseases; Tooth Extraction; Tooth Socket | 2001 |
Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.
Topics: Adult; Anti-Infective Agents; Aztreonam; Cefdinir; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gonorrhea; Humans; Japan; Male; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Neisseria gonorrhoeae; Roxithromycin; Spectinomycin; Urethritis | 2001 |
Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2001 |
Antibacterial action of several tannins against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Blood Coagulation; Cefdinir; Cephalosporins; Colony Count, Microbial; Culture Media; Drug Therapy, Combination; Humans; Hydrolyzable Tannins; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Tannins | 2001 |
Management update of acute bacterial rhinosinusitis and the use of cefdinir.
Topics: Acute Disease; Anti-Bacterial Agents; Bacterial Infections; Cefdinir; Cephalosporins; Humans; Rhinitis; Sinusitis | 2002 |
Effects of organic anion, organic cation, and dipeptide transport inhibitors on cefdinir in the isolated perfused rat kidney.
Topics: Animals; Biological Transport; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Dipeptides; Kidney; Male; Metabolic Clearance Rate; Probenecid; Protein Binding; Rats; Rats, Sprague-Dawley; Tetraethylammonium | 2003 |
[Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cefdinir; Cephalosporins; Ciprofloxacin; Dosage Forms; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Macrolides; Ofloxacin; Otorhinolaryngologic Diseases; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Urinary Tract Infections | 2002 |
[Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Drug Resistance, Bacterial; Humans; Japan; Product Surveillance, Postmarketing; Time Factors | 2002 |
An alternative procedure for preparation of cefdinir.
Topics: Cefdinir; Cephalosporins; Technology, Pharmaceutical | 2003 |
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
Topics: Acute Disease; Ampicillin; Anti-Infective Agents; Azithromycin; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Clarithromycin; Enterobacteriaceae; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Penicillin G; Pharyngitis; Streptococcus pneumoniae; Streptococcus pyogenes; Tonsillitis | 2003 |
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).
Topics: Administration, Oral; Anti-Bacterial Agents; Brazil; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Sensitivity and Specificity; Streptococcus pneumoniae | 2003 |
Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes.
Topics: Biotransformation; Cefdinir; Cefixime; Cephalosporins; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Isoenzymes; Kinetics; Microsomes, Liver | 2004 |
Fungal biofilm formation on cochlear implant hardware after antibiotic-induced fungal overgrowth within the middle ear.
Topics: Anti-Infective Agents; Antifungal Agents; Beckwith-Wiedemann Syndrome; Biofilms; Candida; Cefdinir; Cephalosporins; Cochlear Implants; Female; Humans; Infant; Ofloxacin; Otitis Media | 2004 |
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.
Topics: Anti-Infective Agents; Bacteria; Cefdinir; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Gram-Positive Cocci; Humans; Klebsiella; Microbial Sensitivity Tests; North America; Skin Diseases, Bacterial; Soft Tissue Infections | 2004 |
[In vitro antibacterial activity of cefdinir against isolates of respiratory tract pathogens in children].
Topics: Anti-Bacterial Agents; Bacteria; Cefdinir; Cephalosporins; Child; Humans; Microbial Sensitivity Tests; Respiratory System | 2004 |
Estimation of the intervention effect in a non-randomized study with pre- and post-mismeasured binary responses.
Topics: Acoustic Impedance Tests; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bias; Cefdinir; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Computer Simulation; Diagnostic Errors; Humans; Infant; Otitis Media with Effusion; Treatment Outcome | 2005 |
Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections.
Topics: Anti-Infective Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; North America; Staphylococcus; Urinary Tract Infections | 2005 |
[Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
Topics: Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pneumoniae | 2004 |
Cefdinir: an oral alternative to parenteral cephems.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 2005 |
Effects of amoxicillin and cefdinir on nasopharyngeal bacterial flora.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefdinir; Cephalosporins; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Otitis Media with Effusion; Retrospective Studies; Treatment Outcome | 2005 |
A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Multicenter Studies as Topic; Penicillins; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2005 |
Efficacy of penicillin versus cefdinir in eradication of group A streptococci and tonsillar flora.
Topics: Cefdinir; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Palatine Tonsil; Penicillins; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2005 |
Microdialysis studies of the distribution of antibiotics into chinchilla middle ear fluid.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Chinchilla; Disease Models, Animal; Dose-Response Relationship, Drug; Ear, Middle; Half-Life; Microbial Sensitivity Tests; Microdialysis; Otitis Media; Streptococcus pneumoniae | 2005 |
Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefdinir; Cephalosporins; Child; Child, Preschool; Colony Count, Microbial; Cross Infection; Female; Humans; Infant; Infusions, Parenteral; Male; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract Infections; Urine | 2006 |
Selective method for the determination of cefdinir in human plasma using liquid chromatography electrospray ionization tandam mass spectrometry.
Topics: Anti-Infective Agents; Calibration; Cefdinir; Cephalosporins; Humans; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2006 |
Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
Topics: Adolescent; Adult; Ampicillin; Anti-Infective Agents, Urinary; Cefdinir; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; North America; Outpatients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?
Topics: Administration, Oral; Anti-Infective Agents; Cefdinir; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections | 2006 |
Cefdinir: A comparative study of anhydrous vs. monohydrate form. Microstructure and tabletting behaviour.
Topics: Anti-Infective Agents; Calorimetry, Differential Scanning; Cefdinir; Cephalosporins; Chemistry, Pharmaceutical; Microscopy, Electron, Scanning; Molecular Structure; Particle Size; Photomicrography; Polysaccharides; Solubility; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tablets; Technology, Pharmaceutical; Thermogravimetry; Transition Temperature; Water; X-Ray Diffraction | 2006 |
Isolation, structural elucidation and characterization of impurities in Cefdinir.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Drug Contamination; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Spectroscopy, Fourier Transform Infrared | 2007 |
Bayesian estimation of intervention effect with pre- and post-misclassified binomial data.
Topics: Acoustic Impedance Tests; Algorithms; Anti-Bacterial Agents; Bayes Theorem; Bias; Cefdinir; Cephalosporins; Clinical Trials as Topic; Computer Simulation; Diagnostic Errors; Diagnostic Tests, Routine; Humans; Likelihood Functions; Models, Statistical; Monte Carlo Method; Otitis Media; Probability; Sample Size; Treatment Outcome | 2007 |
Voltammetric behavior of cefdinir in solubilized system.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Electrochemistry; Electrodes; Electrolysis; Hydrogen-Ion Concentration; Molecular Structure; Solubility; Surface Properties; Surface-Active Agents | 2008 |
Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity.
Topics: Anti-Bacterial Agents; Cefdinir; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2008 |
Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.
Topics: Ampicillin; Bacterial Proteins; beta-Lactams; Carbapenems; Cefdinir; Cefprozil; Cephalosporins; Gene Transfer, Horizontal; Haemophilus influenzae; Mutation; Penicillin-Binding Proteins | 2008 |
A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder.
Topics: Acetaminophen; Bile Acids and Salts; Bile Duct Diseases; Bilirubin; Cefdinir; Cephalosporins; Child; Erythema Multiforme; Humans; Male; Methylprednisolone; Syndrome | 2008 |
Nonbloody, red stools from coadministration of cefdinir and iron-supplemented infant formulas.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Dietary Supplements; Drug Labeling; Feces; Humans; Infant; Infant Formula; Iron; Male; Otitis Media | 2008 |
Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Chemical and Drug Induced Liver Injury; Humans; Male; Obesity, Morbid; Pharyngitis; Streptococcal Infections; Young Adult | 2008 |
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections | 2009 |
Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Comorbidity; Drug Therapy, Combination; Female; Fever; Hemolysis; Humans; Male; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Time Factors; Tonsillitis | 2009 |
Visual diagnosis: four infants who have red, "bloody" stools.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child, Preschool; Diagnosis, Differential; Diarrhea, Infantile; Drug Interactions; Female; Food Coloring Agents; Gastrointestinal Hemorrhage; Humans; Infant; Intussusception; Iron; Male | 2009 |
Infant male with blood-colored stools.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Color; Diagnosis, Differential; Feces; Humans; Infant; Male | 2009 |
Improved selective isolation of Bordetella pertussis by use of modified cyclodextrin solid medium.
Topics: Agar; Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Bordetella pertussis; Candida albicans; Cefdinir; Cephalosporins; Child; Colony Count, Microbial; Culture Media; Cyclodextrins; Humans; Nasopharynx; Sensitivity and Specificity; Species Specificity | 2009 |
Another vacation, another medical 'crisis'.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Diagnosis, Differential; Gastrointestinal Hemorrhage; Humans; Infant; Male; Mexico; Otitis Media; Travel | 2010 |
Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
Topics: Anti-Bacterial Agents; Calorimetry, Differential Scanning; Cefdinir; Cephalosporins; Chemistry, Pharmaceutical; Chromatography, Supercritical Fluid; Crystallography, X-Ray; Kinetics; Microscopy, Electron, Scanning; Nanotechnology; Particle Size; Powder Diffraction; Solubility; Solvents; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical; Thermogravimetry | 2010 |
In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Korea; Respiratory Tract Infections; Streptococcus pneumoniae | 2010 |
Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Rifampin; Wound Infection | 2011 |
Spectophotometric methods for determination of cefdinir in pharmaceutical formulations via derivatization with 1,2-naphthoquinone-4-sulfonate and 4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole.
Topics: 4-Chloro-7-nitrobenzofurazan; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Chemistry, Pharmaceutical; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Limit of Detection; Linear Models; Naphthoquinones; Reproducibility of Results; Sodium Hydroxide; Solvents; Spectrophotometry, Ultraviolet; Temperature | 2012 |
Simultaneous determination of cefdinir and cefixime in human plasma by RP-HPLC/UV detection method: Method development, optimization, validation, and its application to a pharmacokinetic study.
Topics: Cefdinir; Cefixime; Cephalosporins; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Humans | 2011 |
Development and validation of a rapid HPLC method for the determination of cefdinir in beagle dog plasma integrated with an automatic on-line solid-phase extraction following protein precipitation in the 96-well plate format.
Topics: Acetonitriles; Animals; Cefdinir; Cephalosporins; Chemical Precipitation; Chromatography, High Pressure Liquid; Dogs; Drug Stability; Limit of Detection; Linear Models; Methanol; Perchlorates; Reproducibility of Results; Solid Phase Extraction | 2012 |
[Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy].
Topics: Cefdinir; Ceftizoxime; Cephalosporins; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Contamination; Mass Spectrometry; Quality Control | 2012 |
Determination of cefdinir levels in rat plasma and urine by high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral and intravenous administration of cefdinir.
Topics: Administration, Intravenous; Administration, Oral; Animals; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Limit of Detection; Male; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2013 |
Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Bacterial Agents; beta-Cyclodextrins; Calorimetry, Differential Scanning; Cefdinir; Cephalosporins; Chemical Phenomena; Drug Compounding; Drug Stability; Excipients; Freeze Drying; Hydrophobic and Hydrophilic Interactions; Kinetics; Microscopy, Electron, Scanning; Particle Size; Phase Transition; Powder Diffraction; Sequestering Agents; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2013 |
Impact of targeted specific antibiotic delivery for gut microbiota modulation on high-fructose-fed rats.
Topics: Animals; Anti-Bacterial Agents; Blood Chemical Analysis; Body Weight; Cefdinir; Cephalosporins; Dietary Carbohydrates; Drinking; Drug Liberation; Feces; Fructose; Glucose Tolerance Test; Intestines; Liver; Male; Microbiota; Microspheres; Rats; Rats, Wistar | 2014 |
Balancing the benefits and risks of empirical antibiotics for sinusitis: a teachable moment.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cefdinir; Cephalosporins; Enterocolitis, Pseudomembranous; Fatal Outcome; Humans; Immunocompromised Host; Infliximab; Male; Rhinitis; Risk Assessment; Sinusitis | 2014 |
Biodegradation of cefdinir by a novel yeast strain, Ustilago sp. SMN03 isolated from pharmaceutical wastewater.
Topics: Anti-Bacterial Agents; Biotransformation; Cefdinir; Cephalosporins; Chromatography, Liquid; Hydrogen-Ion Concentration; Kinetics; Mass Spectrometry; Spectroscopy, Fourier Transform Infrared; Temperature; Ustilago; Wastewater | 2014 |
Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Calcitriol; Cefadroxil; Cefdinir; Cephalosporins; Dogs; Down-Regulation; Drug Interactions; Humans; Injections, Intravenous; Kidney; Ligands; Liver; Madin Darby Canine Kidney Cells; Male; Metabolic Clearance Rate; Models, Biological; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Peptide Transporter 1; Rats, Sprague-Dawley; Receptors, Calcitriol; Renal Elimination; RNA, Messenger; Symporters; Tissue Distribution; Transfection | 2014 |
Achromobacter buckle infection diagnosed by a 16S rDNA clone library analysis: a case report.
Topics: Achromobacter; Anti-Bacterial Agents; Betamethasone; Cefdinir; Cephalosporins; Device Removal; DNA, Bacterial; DNA, Ribosomal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Gram-Negative Bacterial Infections; Humans; Middle Aged; Moxifloxacin; Polymerase Chain Reaction; Prosthesis-Related Infections; Retinal Detachment; RNA, Ribosomal, 16S; Scleral Buckling | 2014 |
Facial vein thrombophlebitis: an uncommon complication of sinusitis.
Topics: Anti-Bacterial Agents; Anticoagulants; Cefdinir; Cephalosporins; Child; Contrast Media; Diagnosis, Differential; Enoxaparin; Face; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Sinusitis; Thrombophlebitis; Tomography, X-Ray Computed | 2015 |
Gone but not forgotten: a case of respiratory distress.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Cefdinir; Ceftriaxone; Cephalosporins; Child; Diagnosis, Differential; Dyspnea; Epiglottis; Epiglottitis; Humans; Intubation, Intratracheal; Male; Radiography; Vancomycin | 2015 |
Potentiality of yeast Candida sp. SMN04 for degradation of cefdinir, a cephalosporin antibiotic: kinetics, enzyme analysis and biodegradation pathway.
Topics: Anti-Bacterial Agents; Biodegradation, Environmental; Candida; Cefdinir; Cephalosporins; Chromatography, Liquid; Kinetics; Mass Spectrometry; Molecular Sequence Data; RNA, Fungal; RNA, Ribosomal, 18S; Water Pollutants, Chemical | 2015 |
Mass Spectral Profile for Rapid Differentiating Beta-Lactams from Their Ring-Opened Impurities.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefaclor; Cefdinir; Cefixime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Mass Spectrometry | 2015 |
[Analysis of the interaction between cefdinir and bovine serum albumin by spectrometry].
Topics: Binding Sites; Cefdinir; Cephalosporins; Serum Albumin, Bovine; Spectrophotometry, Ultraviolet; Thermodynamics | 2015 |
Optimizing the spectrofluorimetric determination of cefdinir through a Taguchi experimental design approach.
Topics: Cefdinir; Cephalosporins; Cerium; Fluorescence; Molecular Structure; Research Design; Spectrometry, Fluorescence; Sulfates | 2016 |
Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Topics: Administration, Oral; Animals; Biological Availability; Calorimetry, Differential Scanning; Cefdinir; Cephalosporins; Chemistry, Pharmaceutical; Drug Compounding; Drug Liberation; Excipients; Male; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Permeability; Rats; Rats, Wistar; Solubility; Suspensions; X-Ray Diffraction | 2016 |
Application and optimization of organic-inorganic hybrid monolithic capillary electrochromatography for in vivo cefdinir determination with microdialysis.
Topics: Animals; Anti-Bacterial Agents; Capillary Electrochromatography; Cefdinir; Cephalosporins; Microdialysis; Rats | 2016 |
[Construction of the quantitative structure retention relationship of cefdinir related substances].
Topics: Cefdinir; Cephalosporins; Chromatography; Models, Chemical; Quality Control; Structure-Activity Relationship | 2015 |
Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefdinir; Cephalosporins; Cytoskeletal Proteins; Drug Synergism; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prodrugs; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2016 |
Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cefdinir; Cephalosporins; Chromatography, Gas; Dietary Carbohydrates; Fatty Acids, Volatile; Feces; Fermentation; Gastrointestinal Microbiome; Male; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity | 2016 |
Cefdinir Solid Dispersion Composed of Hydrophilic Polymers with Enhanced Solubility, Dissolution, and Bioavailability in Rats.
Topics: Administration, Oral; Animals; Biological Availability; Calorimetry, Differential Scanning; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Carriers; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Male; Microscopy, Electron, Scanning; Molecular Structure; Polymers; Rats; Solubility; Tandem Mass Spectrometry; Viscosity; X-Ray Diffraction | 2017 |
INVASIVE SALMONELLOSIS PRESENTING AS A LUNG ABSCESS: A CASE REPORT.
Topics: Anti-Bacterial Agents; Cefdinir; Ceftriaxone; Cephalosporins; Humans; Lung Abscess; Male; Middle Aged; Salmonella Infections | 2017 |
Pharmacokinetic changes of cefdinir and cefditoren and its molecular mechanisms in acute kidney injury in rats.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Cisplatin; Disease Models, Animal; Gene Expression Regulation; Kidney; Male; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Rats, Wistar; Renal Elimination | 2018 |
Use of oral third generation cephalosporins and quinolones and occurrence of antibiotic-resistant strains in the neurogenic bladder (NB) outpatient setting: a retrospective chart audit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Cefdinir; Cephalosporins; Drug Prescriptions; Drug Resistance, Bacterial; Female; Hospitals, Rehabilitation; Humans; Japan; Levofloxacin; Male; Middle Aged; Outpatients; Quinolones; Retrospective Studies; Spinal Cord Injuries; Urinary Bladder, Neurogenic; Young Adult | 2020 |
The effect of generic market entry on antibiotic prescriptions in the United States.
Topics: Anti-Bacterial Agents; Aztreonam; Cefdinir; Cefprozil; Cephalosporins; Costs and Cost Analysis; Databases, Pharmaceutical; Drug Costs; Drug Industry; Drug Prescriptions; Drugs, Generic; Humans; United States | 2021 |
Cefdinir-Associated "Bloody Stools": No Need to Scope.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Gastrointestinal Hemorrhage; Humans | 2021 |
Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.
Topics: Animals; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cephalosporins; Dysbiosis; Inflammation; Mice; Streptococcus pneumoniae | 2022 |
Bloody Stool: Is It Really Scary in Kids? Four Benign Cases.
Topics: Cefdinir; Cephalosporins; Child; Gastrointestinal Hemorrhage; Humans | 2022 |